Targeting adaptive cellular responses to mitochondrial bioenergetic deficiencies in human disease
- PMID: 34510753
- PMCID: PMC8917243
- DOI: 10.1111/febs.16195
Targeting adaptive cellular responses to mitochondrial bioenergetic deficiencies in human disease
Abstract
Mitochondrial dysfunction is increasingly appreciated as a central contributor to human disease. Oxidative metabolism at the mitochondrial respiratory chain produces ATP and is intricately tied to redox homeostasis and biosynthetic pathways. Metabolic stress arising from genetic mutations in mitochondrial genes and environmental factors such as malnutrition or overnutrition is perceived by the cell and leads to adaptive and maladaptive responses that can underlie pathology. Here, we will outline cellular sensors that react to alterations in energy production, organellar redox, and metabolites stemming from mitochondrial disease (MD) mutations. MD is a heterogeneous group of disorders primarily defined by defects in mitochondrial oxidative phosphorylation from nuclear or mitochondrial-encoded gene mutations. Preclinical therapies that improve fitness of MD mouse models have been recently identified. Targeting metabolic/energetic deficiencies, maladaptive signaling processes, and hyper-oxygenation of tissues are all strategies aside from direct genetic approaches that hold therapeutic promise. A further mechanistic understanding of these curative processes as well as the identification of novel targets will significantly impact mitochondrial biology and disease research.
Keywords: hypoxia; mTORC1; metabolism; mitochondrial disease; mitochondrial dysfunction; mitochondrial signaling; oxidative stress; reactive oxygen species; redox homeostasis.
© 2021 Federation of European Biochemical Societies.
Conflict of interest statement
Conflict of interest
The authors declare no conflict of interest.
Figures

References
-
- Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ, Goodman RP, Grabarek Z, Haas ME, Hung WHW, Joshi PR, Jourdain AA, Kim SH, Kotrys AV, Lam SS, McCoy JG, Meisel JD, Miranda M, Panda A, Patgiri A, Rogers R, Sadre S, Shah H, Skinner OS, To TL, Walker MA, Wang H, Ward PS, Wengrod J, Yuan CC, Calvo SE & Mootha VK (2020) MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations, Nucleic Acids Res. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources